A kind of bursa active hexapeptide for promoting the immune response of bird flu and/or Newcastle disease vaccine and its application
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- NANJING AGRICULTURAL UNIVERSITY
- Publication Date
- 2019-10-11
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of veterinary biological products, and in particular relates to a bursa active hexapeptide capable of promoting the immune response of the vaccine avian influenza and / or the dual vaccine with Newcastle disease and its application. Background technique
[0002] Avian influenza (Avian influenza, AI) is an infection or disease syndrome caused by avian influenza virus (Avian influenza virus, AIV). After poultry are infected with AIV, some do not show clinical symptoms, and some show a decrease in egg production. And respiratory diseases, and even lead to systemic diseases, the mortality rate can reach 100%. Therefore, avian influenza can be divided into low pathogenic avian influenza (LPAI) and highly pathogenic avian influenza (HPAI) according to the degree of pathogenicity. H9N2 subtype avian influenza virus is one of the most widespread low-pathogenic avian influenza viruses in the world. Its impact on poult...